| Stephanie Elizabeth Jones, CRNA | |
|
332 W Broadway, Suite 810, Louisville, KY 40202-2130 | |
| (502) 583-0909 | |
| (502) 583-0913 |
| Full Name | Stephanie Elizabeth Jones |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 15 Years |
| Location | 332 W Broadway, Louisville, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043540636 | NPI | - | NPPES |
| 1096873 | Other | KY | KY RN |
| 6363A | Other | KY | CRNA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 1096873 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Louisville Hospital | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Louisville Physicians Inc | 3476725599 | 1102 |
News Archive
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced it has presented data demonstrating that its epigenetic ConfirmMDx for Prostate Cancer test can aid urologists in identifying patients who may avoid a repeat prostate biopsy.
Today, patients have a wide selection of colorectal cancer screening exams from which to choose, unlike with other types of cancers.
The year 2009 will be remembered as a year of many firsts for lupus, including the first successful phase III clinical trial of a potential new treatment for lupus, the launch of the first-ever Ad Council public awareness campaign for lupus, and the first comprehensive report on the barriers to lupus drug development. And it appears there are no signs of any slowing of momentum as we enter the New Year.
The drugmaker Pfizer, one of the companies behind the Pfizer-BioNTech vaccine, or BNT162b2, awaits the green light to develop a COVID-19 booster shot that can protect against emerging variants. Pfizer's COVID-19 vaccine has been shown to be 95% effective in an ongoing large-scale clinical trial against the original SARS-CoV-2 strain.
Imagine a close friend tells you she has dementia. Would you avoid her for fear of being embarrassed by what she might say or do? According to a recent poll by Alzheimer's Disease International, 40 per cent of people with dementia reported they had been avoided or treated differently after diagnosis. It's no surprise, then, that one in four respondents cited stigma as a reason to conceal their diagnosis.
› Verified 8 days ago
| Entity Name | University Of Louisville Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366722316 PECOS PAC ID: 3476725599 Enrollment ID: O20111017000036 |
News Archive
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced it has presented data demonstrating that its epigenetic ConfirmMDx for Prostate Cancer test can aid urologists in identifying patients who may avoid a repeat prostate biopsy.
Today, patients have a wide selection of colorectal cancer screening exams from which to choose, unlike with other types of cancers.
The year 2009 will be remembered as a year of many firsts for lupus, including the first successful phase III clinical trial of a potential new treatment for lupus, the launch of the first-ever Ad Council public awareness campaign for lupus, and the first comprehensive report on the barriers to lupus drug development. And it appears there are no signs of any slowing of momentum as we enter the New Year.
The drugmaker Pfizer, one of the companies behind the Pfizer-BioNTech vaccine, or BNT162b2, awaits the green light to develop a COVID-19 booster shot that can protect against emerging variants. Pfizer's COVID-19 vaccine has been shown to be 95% effective in an ongoing large-scale clinical trial against the original SARS-CoV-2 strain.
Imagine a close friend tells you she has dementia. Would you avoid her for fear of being embarrassed by what she might say or do? According to a recent poll by Alzheimer's Disease International, 40 per cent of people with dementia reported they had been avoided or treated differently after diagnosis. It's no surprise, then, that one in four respondents cited stigma as a reason to conceal their diagnosis.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Elizabeth Jones, CRNA 332 W Broadway, Suite 810, Louisville, KY 40202-2130 Ph: (502) 583-0909 | Stephanie Elizabeth Jones, CRNA 332 W Broadway, Suite 810, Louisville, KY 40202-2130 Ph: (502) 583-0909 |
News Archive
MDxHealth SA, a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced it has presented data demonstrating that its epigenetic ConfirmMDx for Prostate Cancer test can aid urologists in identifying patients who may avoid a repeat prostate biopsy.
Today, patients have a wide selection of colorectal cancer screening exams from which to choose, unlike with other types of cancers.
The year 2009 will be remembered as a year of many firsts for lupus, including the first successful phase III clinical trial of a potential new treatment for lupus, the launch of the first-ever Ad Council public awareness campaign for lupus, and the first comprehensive report on the barriers to lupus drug development. And it appears there are no signs of any slowing of momentum as we enter the New Year.
The drugmaker Pfizer, one of the companies behind the Pfizer-BioNTech vaccine, or BNT162b2, awaits the green light to develop a COVID-19 booster shot that can protect against emerging variants. Pfizer's COVID-19 vaccine has been shown to be 95% effective in an ongoing large-scale clinical trial against the original SARS-CoV-2 strain.
Imagine a close friend tells you she has dementia. Would you avoid her for fear of being embarrassed by what she might say or do? According to a recent poll by Alzheimer's Disease International, 40 per cent of people with dementia reported they had been avoided or treated differently after diagnosis. It's no surprise, then, that one in four respondents cited stigma as a reason to conceal their diagnosis.
› Verified 8 days ago
Benjamin Martin Choi Sampedro, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 200 E Chestnut St, Louisville, KY 40202 Phone: 214-687-0001 | |
Mrs. Shelby Victoria Cofer, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-562-3000 | |
Marian Antonette Cochiaosue-avery, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-852-1735 Fax: 502-852-6056 | |
Jessica Earline Luvisi, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 231 E Chestnut St, Louisville, KY 40202 Phone: 502-629-6000 | |
Chad Riddle, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4034 Saint Ives Ct, Louisville, KY 40207 Phone: 502-640-8349 Fax: 502-749-9202 | |
Mr. Scott M. Beyl, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-852-6901 Fax: 502-852-6056 | |
Lauren Elise Coles, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 530 S Jackson St, Louisville, KY 40202 Phone: 502-852-1735 Fax: 502-852-6056 |